Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Uterine Cervical Neoplasms 4Breast Neoplasms 4Oropharyngeal Neoplasms 3Sarcoma 2Prostatic Neoplasms 2Lung Neoplasms 2Esophageal Neoplasms 2Cholangiocarcinoma 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2Anus Neoplasms 2Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Thymus Neoplasms 1Testicular Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Sarcoma, Ewing 1Rhabdoid Tumor 1Rectal Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neuroendocrine Tumors 1Neoplasms, Unknown Primary 1Neoplasms 1Mouth Neoplasms 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Hematologic Neoplasms 1

Interventions

pembrolizumab 7Cisplatin 7Magnetic Resonance Spectroscopy 6Specimen Handling 5Radiotherapy, Intensity-Modulated 4Carboplatin 4Taxes 3Radiotherapy 3Platinum 3Paclitaxel 31,2-diaminocyclohexaneplatinum II citrate 3durvalumab 2Optical Imaging 2Nivolumab 2Biopsy 2peposertib 1niraparib 1nabiximols 1ipatasertib 1dostarlimab 1dehydroftorafur 1cemiplimab 1atezolizumab 1X-Rays 1Tretinoin 1Surveys and Questionnaires 1Spectrometry, Fluorescence 1Radiosurgery 1Radiation 1Proflavine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Mouth Neoplasms × Fluorodeoxyglucose F18 × Clear all
NCT04533750 2026-04-13

Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin

National Cancer Institute (NCI)

Phase 1 Active not recruiting
21 enrolled
Head & Neck

Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡